What kind of company is CRISPR, the biotech startup heavily invested in by Cathie Wood?CRISPR Therapeutics (NASDAQ: CRSP) is a biotechnology company developing innovative gene therapies. Its core technology is the CRISPR/Cas9 gene editing platform. Leveraging its leading DNA gene editing technology, CRISPR has sparked a revolutionary change in the medical field, attracting the attention of renowned investor Cathie Wood. Through her Ark Invest, she has made a significant investment in CRISPR Therapeutics. This not only reflects her confidence in the company's future growth potential but also demonstrates the importance of gene editing technology in modern medicine. Currently, CRISPR Therapeutics is focusing on several key medical areas, including blood diseases, cancer, and immune system disorders, and has already achieved progress in clinical trials.
ChainNewsAbmedia·01-04 02:34